Displaying 2081 - 2100 of 9022
FTC Sending Refund Checks Totaling More Than $11.6 Million to Businesses and Organizations That Paid for Unordered Office and Cleaning Supplies
LabMD, Inc. v. Federal Trade Commission
The Federal Trade Commission filed a complaint against medical testing laboratory LabMD, Inc. alleging that the company failed to reasonably protect the security of consumers’ personal data, including medical information.
Standard Industries LLC
In July 2017, the FTC obtained court orders against this Maryland-based office supply operation charged with tricking small businesses, non-profit organizations, and other consumers into paying for overpriced office and cleaning supplies they never ordered. The stipulated orders setting the FTC’s complaint barred the company and its principals from telemarketing office and cleaning supplies. It also imposed a financial judgment against them, resulting in the Commission sending refund checks totaling more than $11.6 million to small businesses and other organizations in August 2019.
Consumers and Class Action Notices: An FTC Workshop
FTC Revises List of Companies Subject to Broadband Privacy Study
Operator of Colorado Technical University and American InterContinental University Will Pay $30 Million to Settle FTC Charges it Used Deceptive Lead Generators to Market its Schools
Telemarketing Sales Rule
Letter from Joshua S. Millard, Staff Attorney, Division of Enforcement, Bureau of Consumer Protection
Most Telemarketer Fees to Access the FTC’s National Do Not Call Registry to Increase in FY 2020
FTC to Hold Workshop on Made in USA Advertising and Marketing Claims
Promoters of Deceptive Chain Referral Schemes Involving Cryptocurrencies Agree to Settlement with FTC
FTC Refunds Consumers Who Bought FlexiPrin Joint Pain Supplement
XXL Impressions LLC / J2 Response L.L.P. / Synergixx, LLC
In February 2017, the FTC and the Maine AG’s office announced a complaint and three settlements with dietary supplement marketers who allegedly used radio infomercials deceptively formatted as talk shows and print ads featuring fictitious endorsers to advertise supplements purporting to improve memory and to reduce back and joint pain. The settlement orders resolving charges against the named in the complaint bar them from making similar deceptive claims, and prohibit them from engaging in a wide range of marketing practices that have caused serious financial injury to consumers. In April 2015, the FTC sent refunds to consumers who bought one of the company deceptively marketed supplements, CogniPrin. In August 2019, the FTC send refunds to consumers who bought FlexiPrin, another supplement the company sold.
FTC Approves Final Consent Order Settling Charges That Background Screening Company Falsely Claimed Compliance with EU-U.S. Privacy Shield Framework
FTC Refunds Consumers Who Bought Deceptively Marketed and Advertised “Nobetes” Diabetes Treatment Supplement
SecurTest, Inc., In the Matter of
The FTC alleged that while SecurTest initiated a Privacy Shield application in September 2017 with the U.S. Department of Commerce, the company did not complete the steps necessary to be certified as complying with the frameworks. Because it failed to complete certification, SecurTest was not a certified participant in the frameworks, despite representations to the contrary on its website. The settlement with the FTC prohibits SecurTest from misrepresenting its participation in any privacy or security program sponsored by a government, self-regulatory, or standard-setting organization, including the EU-U.S. Privacy Shield and Swiss-U.S. Privacy Shield frameworks. It also must comply with reporting and compliance requirements.
Nobetes Corp.
In December 2018, officers of a company that marketed and sold Nobetes, a pill they claimed treats diabetes, settled an FTC complaint alleging that the advertising claims for the product are false or unsubstantiated. The order settling the FTC’s complaint prohibits the company and its officers from undertaking future deceptive practices, including making unsubstantiated health claims, misleading consumers about the terms of “free trial” offers, billing consumers without their consent, and other practices related to the use of “expert” endorsements and consumer testimonials. In addition, it requires them to pay money to provide refunds to consumers who bought the product. In August 2019, the FTC returned $60,791 to these consumers.
Displaying 2081 - 2100 of 9022